WUXI BIOLOGICS-00000083
Research WUXI BIOLOGICS-00000083 (1FW2) on Bullrun: market cap EUR 25.69B, P/E 39.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1FW2
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 25.69B
- P/E39.0
- Financial periodFY2025
- RevenueCNY 21.79B
- Revenue growth16.7%
- Net incomeCNY 4.91B
- Free cash flowCNY 2.61B
- Gross margin46.0%
Valuation Snapshot
latest market cap is EUR 25.69B; P/E is 39.0.
Peer valuation comparison
Latest P/E is 39x versus a Healthcare sector median of 21.69x (79.8% above).
Latest P/E is 39x versus a China median of 16.26x (139.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 21.79B | CNY 4.91B | CNY 2.61B | 46.0% | 1.16 | CNY 9.21B | CNY 3.10B | CNY 47.25B |
| FY2024 | CNY 18.68B | CNY 3.36B | CNY 1.29B | 41.0% | 0.78 | CNY 8.28B | CNY 4.94B | CNY 41.82B |
| FY2023 | CNY 17.03B | CNY 3.40B | CNY 437.20M | 40.1% | 0.77 | CNY 9.67B | CNY 4.56B | CNY 40.33B |
| FY2022 | CNY 15.27B | CNY 4.42B | -CNY 326.72M | 44.0% | 1.01 | CNY 6.40B | CNY 4.42B | CNY 35.05B |
| FY2021 | CNY 10.29B | CNY 3.39B | -CNY 3.09B | 46.9% | 0.77 | CNY 9.00B | CNY 4.30B | CNY 32.28B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-30 | EUR 25.69B | 39.0 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About WUXI BIOLOGICS-00000083
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is WUXI BIOLOGICS-00000083's market cap?
WUXI BIOLOGICS-00000083's market capitalization is EUR 25.69B.
What is WUXI BIOLOGICS-00000083's P/E ratio?
WUXI BIOLOGICS-00000083's price-to-earnings (P/E) ratio is 39.0.
What does WUXI BIOLOGICS-00000083 do?
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC.